Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in Pediatric ILD
NCT02615938Phase 2Terminated
- Start
- Aug 2015
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in interstitial lung disease (ILD). Started Aug 2015; status: terminated.
02
Drugs
hydroxychloroquine
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT02615938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02615938.